GERON CORP Settlement Liabilities, Current
GERON CORP (GERN) had Settlement Liabilities, Current of $7.00 million as of 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Notes
us-gaap:SettlementLiabilitiesCurrent · last filed 2023-11-02
- 2023-09-30: Settlement Liabilities, Current $7.00M.
- 2023-06-30: Settlement Liabilities, Current $7.00M.
- 2023-03-31: Settlement Liabilities, Current $8.35M.
- 2022-12-31: Settlement Liabilities, Current $8.35M.
| Period end | Settlement Liabilities, Current |
|---|---|
| 2023-09-30 | $7.00M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $7.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $8.35M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.35M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |